BMR vs ALLR
Comparison between Beamr Imaging Ltd (BMR, Company) and Allarity Therapeutics Inc (ALLR, Company).
BMR is from the Technology sector, while ALLR is from the Healthcare sector.
BMR vs ALLR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BMR
$18M
ALLR
$18M
Max Drawdown
Winner
BMR
92.67%
ALLR
100.00%
Sharpe Ratio
BMR
-1.19
Winner
ALLR
0.44
5Y Beta
BMR
1.74
Winner
ALLR
0.00
Industry
BMR
Software - Application
ALLR
Biotechnology
P/E Ratio
Winner
BMR
-3.07
ALLR
-1.62
PEG Ratio
BMR
-0.04
ALLR
N/A
Debt to Equity
Winner
BMR
0.00%
ALLR
290.17%
Free Cash Flow Yield
Winner
BMR
-25.58%
ALLR
-91.00%
BMR vs ALLR - Historical Returns
Returns include dividend reinvestment.
1M
BMR
-20.13%
Winner
ALLR
-10.77%
3M
BMR
-37.37%
Winner
ALLR
-15.94%
6M
BMR
-42.51%
Winner
ALLR
+11.00%
1Y
BMR
-62.22%
Winner
ALLR
+9.43%
5Y(CAGR)
BMR
N/A
ALLR
-96.80%
Max(CAGR)
Winner
BMR
-27.98%
ALLR
-96.80%
BMR vs ALLR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BMR | ALLR |
|---|---|---|
| 2026 | -32.00% | +1.75% |
| 2025 | -66.95% | -2.70% |
| 2024 | +173.33% | -99.64% |
| 2023 | -60.27% | -99.85% |
| 2022 | N/A | -97.23% |
| 2021 | N/A | -1.20% |
BMR vs ALLR Drawdown Comparison
The maximum drawdown for BMR was -92.67%, occurring on Jul 23, 2026. This drawdown has not yet recovered.
The maximum drawdown for ALLR was -100.00%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The current BMR drawdown is -92.60%. The current ALLR drawdown is -100.00%.
| Rank | BMR | ALLR |
|---|---|---|
| #1 | -92.67% Feb 14, 2024 - Jul 23, 2026 | -100.00% Dec 22, 2021 - Apr 9, 2025 |
| #2 | -78.23% May 25, 2023 - Feb 12, 2024 | N/A |
| #3 | -61.93% Mar 2, 2023 - May 25, 2023 | N/A |
| #4 | -9.59% Feb 28, 2023 - Mar 2, 2023 | N/A |
Correlation
Correlation between BMR and ALLR is 0.04 which considered as a very weak or no correlation - the stocks move independently of each other.
0.04
-101
Select Stocks to Compare
Popular: BMR vs SPYALLR vs SPY
More Comparisons
Compare with similar stocks